7.10
1.28%
+0.09
After Hours:
7.10
GoodRx Holdings Inc stock is currently priced at $7.10, with a 24-hour trading volume of 1.02M.
It has seen a +1.28% increased in the last 24 hours and a +9.74% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $7.05 pivot point. If it approaches the $7.19 resistance level, significant changes may occur.
GoodRx Holdings Inc Stock (GDRX) Financials Data
GoodRx Holdings Inc (GDRX) Revenue 2023
GDRX reported a revenue (TTM) of $750.26 million for the quarter ending December 31, 2023, a -2.12% decline year-over-year.
GoodRx Holdings Inc (GDRX) Net Income 2023
GDRX net income (TTM) was -$8.87 million for the quarter ending December 31, 2023, a +72.99% increase year-over-year.
GoodRx Holdings Inc (GDRX) Cash Flow 2023
GDRX recorded a free cash flow (TTM) of $82.53 million for the quarter ending December 31, 2023, a -9.87% decrease year-over-year.
GoodRx Holdings Inc (GDRX) Earnings per Share 2023
GDRX earnings per share (TTM) was -$0.02 for the quarter ending December 31, 2023, a +74.42% growth year-over-year.
GoodRx Holdings Inc Stock (GDRX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Voermann Karsten | Chief Financial Officer |
Dec 08 '23 |
Option Exercise |
0.00 |
54,064 |
0 |
199,885 |
Wagner Scott | See Remarks |
Nov 30 '23 |
Buy |
5.76 |
21,652 |
124,806 |
182,900 |
Wagner Scott | See Remarks |
Nov 29 '23 |
Buy |
5.90 |
26,348 |
155,482 |
161,248 |
Wagner Scott | See Remarks |
Nov 28 '23 |
Buy |
6.00 |
4,157 |
24,940 |
134,900 |
Wagner Scott | See Remarks |
Nov 17 '23 |
Buy |
5.26 |
26,664 |
140,271 |
130,743 |
Wagner Scott | See Remarks |
Nov 16 '23 |
Buy |
5.16 |
104,079 |
537,204 |
104,079 |
GoodRx Holdings Inc Stock (GDRX) Latest News
Why GoodRx Surged Today
The Motley Fool
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
Benzinga
The Latest Analyst Ratings For GoodRx Holdings
Benzinga
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Benzinga
ELV or GDRX: Which Is the Better Value Stock Right Now?
Zacks Investment Research
About GoodRx Holdings Inc
GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Cap:
|
Volume (24h):